Best Grants for Cancer Nonprofits in Northern Mariana Islands

The National Cancer Institute's PAIRS program aims to explore innovative cancer therapies by leveraging synthetic vulnerabilities that interact with tumor responses to radiation therapy. This initiative supports the development of targeted drug-radiation combinations, focusing on precision medicine to optimize treatment efficacy while minimizing harm to normal tissues. By consolidating prior funding opportunities, PAIRS encourages research that addresses context-dependent vulnerabilities, enhancing therapeutic strategies and aligning with NIH's scientific goals.

The National Human Genome Research Institute (NHGRI) is launching a Notice of Funding Opportunity (NOFO) aimed at enhancing genomic research through the development and distribution of high-value resources. This initiative encourages collaborative efforts in genomic resource development and the integration of data science in clinical applications. While applications are not currently being accepted, prospective applicants are urged to prepare meaningful collaborations and projects ahead of the formal solicitation.

The National Cancer Institute (NCI) invites applications for the validation of biomarkers and assays for cancer detection and treatment. This funding opportunity allows for biphasic or monophasic applications to support both analytical and clinical validation phases. Successful projects will leverage human specimens to develop assays that enhance cancer treatment and prevention, ensuring multidisciplinary collaboration among scientists and clinicians. This initiative aims to improve cancer management through reliable and clinically validated tools.

Cancer research institutions and translational research centers in the Northern Mariana Islands and other U.S. territories can seek funding to advance prevention, early detection, diagnosis, and treatment of organ-specific or closely related cancers. National Institutes of Health SPORE P50 center grants provide US $25,000,000 for state-of-the-art, human biology-based translational cancer research with clear clinical endpoints.

Cancer research institutions and medical centers in the Northern Mariana Islands and other U.S. jurisdictions can seek funding to run clinical oncology career development programs that train clinician-scientists. US Dept. of Health & Human Services: National Institutes of Health supports K12 programs with multi-specialty oncology faculty, mentored research, and individualized career development in clinical and translational cancer research.

US Dept. of Health & Human Services: National Institutes of Health (NIH) provides Northern Mariana Islands cancer research institutions with Cancer Center Support Grants ranging from US $1,200,000 - US $1,500,000 for NCI-designated Cancer Centers. Funding supports center leadership, shared research resources, administration, planning, evaluation, and developmental projects advancing cancer prevention, diagnosis, treatment, and population science.

Postdoctoral researchers conducting cancer-related clinical trials in the Northern Mariana Islands can access funding through grants from the National Institutes of Health to transition into independent, tenure-track or equivalent faculty roles. This award supports early-career investigators as they move from mentored positions to launching competitive, independent oncology research programs.

Research institutions and similar organizations conducting advanced pre-clinical work on nanotechnology-based cancer diagnostics or therapeutics in the Northern Mariana Islands can apply for NIH funding, with awards up to US $1,900,000. With a mission to advance cancer treatment, NIH supports projects maturing nanoparticle or nano-device interventions toward later-stage NCI translational programs.

Cancer and health-disparities research institutions in the Northern Mariana Islands can seek funding to develop multi-level interventions addressing disparities in liver diseases and liver cancer. US Dept. of Health & Human Services: National Institutes of Health supports projects serving U.S. populations experiencing health disparities through this R01 opportunity, with multiple standard and renewal deadlines through 2027.

Focused on cancer and oncology research careers, the National Institutes of Health invites clinical scientists to pursue mentored research development awards supporting biomedical, behavioral, and translational cancer studies. Eligible investigators from underrepresented backgrounds, including those based in the Northern Mariana Islands, receive protected time and training to advance toward independent cancer research funding.

Clinical scientists pursuing mentored cancer research career development can receive support for biomedical, behavioral, or translational oncology projects, including cancer health disparities, in the Northern Mariana Islands and other U.S. jurisdictions. US Dept. of Health & Human Services: National Institutes of Health provides protected time and training through its NCI Continuing Umbrella of Research Experiences (CURE) K08 program.

Postdoctoral fellows and equivalent early-career cancer researchers in the Northern Mariana Islands can seek support to transition into independent, assistant professor–level positions. With a mission to advance biomedical research careers, the National Institutes of Health provides career development funding for oncology and related professional training, offering up to US $150,000 through this K22 award mechanism.

Postdoctoral cancer researchers from nationally underrepresented backgrounds in the Northern Mariana Islands and other eligible U.S. locations can seek support to transition into independent faculty roles. Focused on cancer and biomedical research careers, the National Institutes of Health’s NCI CURE K22 award provides three years of salary and research support “protected time.”

Undergraduate-focused higher education institutions in the Northern Mariana Islands conducting biomedical research, including cancer and oncology projects, can apply for National Institutes of Health Academic Research Enhancement Awards, with awards up to US $375,000. Eligible colleges must award baccalaureate science degrees and have limited prior NIH funding across non-health professional schools.

NIH provides Northern Mariana Islands cancer and health equity researchers with up to US $2,500,000 to study tobacco, alcohol, and cannabis policy impacts. Projects must examine U.S. policies’ effects on use or exposure among populations facing disparities and authentically engage community organizations to advance cancer prevention and health equity.

Grants from NIH help Northern Mariana Islands cancer and health equity researchers study how tobacco, alcohol, and cannabis policies affect use and secondhand exposure in populations experiencing disparities. Eligible projects must be U.S.-based, engage community organizations, and can request up to US $275,000 to advance cancer prevention through policy-focused research.

Research institutions and labs conducting cancer and biomedical imaging studies in the Northern Mariana Islands can access funding through the National Institutes of Health. NIH provides Northern Mariana Islands cancer and oncology programs with up to US $2,500,000 to develop and apply molecular imaging methods to study inflammation in cancer through cross-disciplinary collaborations.

Cancer research institutions and clinical teams integrating imaging and liquid biopsy tumor monitoring during therapy can apply for up to US $2,500,000 from the National Institutes of Health. Focused on cancer and biomedical imaging, this R01 opportunity invites projects that may include patients from the Northern Mariana Islands to study treatment response and resistance.

With a mission to advance cancer research, the National Institutes of Health provides Northern Mariana Islands cancer researchers and institutions with up to US $275,000 to analytically and clinically validate molecular, cellular, and imaging biomarkers. Funding supports assay validation for cancer detection, diagnosis, prognosis, monitoring, treatment response, prevention, control, and toxicity using human samples.

Research institutions and clinical laboratories conducting cancer biomarker assay validation in the Northern Mariana Islands can access funding through the National Institutes of Health. Grants up to US $750,000 support clinical validation of molecular, cellular, and imaging markers for cancer detection, diagnosis, prognosis, monitoring, treatment response, prevention, and control, including harmonization of tests across laboratories.

Northern Mariana Islands cancer and health-disparities research organizations can access funding through the National Institutes of Health to test clinical trials that expand cancer screening and preventive services. Projects must address barriers at multiple levels and partner with community or healthcare providers, focusing on populations experiencing health disparities, including timely follow-up and referrals to accessible care.

Research institutions and eligible organizations in the Northern Mariana Islands studying bariatric surgery and cancer mechanisms can apply for NIH funding; awards up to US $275,000 support feasibility and exploratory development studies. Projects must investigate how bariatric surgery affects cancer risk, focusing on proof-of-concept mechanistic research rather than short-term outcomes.

Cancer research institutions and medical researchers in the Northern Mariana Islands can apply for up to US $2,500,000 to study how bariatric surgery affects cancer risk. Focused on cancer and obesity mechanisms, the National Institutes of Health supports investigator-initiated projects through the National Cancer Institute with multiple standard and renewal deadlines through 2027.

The National Cancer Institute's Youth Enjoy Science Research Education Program (R25) aims to enhance educational opportunities in biomedical research for underrepresented students in grades 6-12 and undergraduates. By fostering diverse participation, the program seeks to inspire interest in cancer research careers and strengthen essential research skills through hands-on experiences. This initiative aligns with the NIH's mission to support education and training in health sciences, ultimately contributing to a more inclusive research community.

The R01 grant program aims to address disparities in liver diseases and liver cancer in the United States. It supports multi-level intervention research targeting populations with significant health disparities. With deadlines spanning from February 2024 to June 2027, this initiative encourages innovative approaches to improve health outcomes in underserved communities, ultimately enhancing public health and reducing inequities in healthcare access and treatment.

The NCI Worta McCaskill-Stevens Career Development Award supports new clinicians committed to research in community oncology and cancer prevention. This funding aims to facilitate their transition to independent research careers and advanced funding mechanisms. Scholars can lead independent community-based clinical trials, conduct ancillary studies, or gain valuable research experience, specifically targeting underserved communities. Applications are due by 5:00 PM local time of the applicant's organization.

The Cancer Prevention and Control Programs aim to eliminate cancer through collaborative efforts among state, territorial, and tribal organizations. Funded by the CDC, this program supports initiatives such as breast and cervical cancer screening, cancer control planning, and cancer surveillance. By fostering partnerships and community involvement, the program seeks to improve health outcomes and achieve the mission of 'All People Free of Cancer.' This comprehensive approach ensures that resources are effectively coordinated to address the cancer burden in communities.